Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Pharma Native ApS
APS
Active
CVR 44114976
Ravnehusvej 10C
Computer consultancy and computer facilities management activities · NACE 6220
Est. 2023
2 employees
www-pharma-native.com
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2025
DKK 990K
-36% vs 2024
EBITDA margin
16.5%
+54% vs 2024
Equity ratio
66.3%
Financial strength
Net profit 2025
DKK 124K
+60% vs 2024
EBITDA — year on year
DKK millions
0M
0M
1M
1M
1M
0M
2023
0M
0%
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
DKK 990K
-36%
EBITDA
DKK 163K
+54%
Net profit
DKK 124K
+60%
Total assets
DKK 386K
-13%
Equity
DKK 256K
-4%
Employees
2
—
Company information
Legal name
Pharma Native ApS
CVR number
44114976
Legal form
Anpartsselskab
NACE code
6220 · Computer consultancy and computer facilities management activities
Founded
12. juni 2023
Share capital
DKK 40.000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Contact
Address
Ravnehusvej 10C
Phone
+4530995258
Email
je@pharma-native.com
Website
www-pharma-native.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Computer consultancy and computer facilities management activities
Companies in Furesø
All Denmark companies
Revenue
DKK millions
0M
1M
1M
2M
2M
1M
2023
2M
2024
1M
2025
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
0M
2025
Income statement
DKK thousands
Item
2023
2024
2025
Revenue
849
1.538
990
Staff expenses
-489
-1.432
-826
EBITDA
359
106
163
Depreciation & amort.
-0
-0
-0
EBIT
359
106
163
Net financials
-9
-5
-4
Profit before tax
350
101
159
Tax
78
23
35
Net profit
271
77
124
Balance sheet
DKK thousands
Item
2023
2024
2025
Total assets
632
444
386
Equity
311
267
256
Long-term debt
0
0
0
Short-term debt
320
177
130
Total debt
320
177
130
Financial ratios
5-year trend
EBITDA margin
16.5%
This company
15.8%
Market median
+4% vs market
2023
2025
Equity ratio
66.3%
This company
38.2%
Market median
+74% vs market
2023
2025
Return on equity
48.4%
This company
18.4%
Market median
+163% vs market
2023
2025
Net profit margin
12.5%
This company
8.1%
Market median
+54% vs market
2023
2025
Asset turnover
2.56×
This company
1.12×
Market median
+129% vs market
2023
2025
Debt / equity
0.51×
This company
0.62×
Market median
+18% vs market
2023
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-06-12 – 2023-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Jacob Ekstrøm
Individual
100.0%
100.0%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Pharma Native ApS also hold positions in
0
other companies.
Person
Role here
Other companies